wave
  • 17Jun
    17Jun
  • Belgium

Companion diagnostics provide highly valuable information to select treatments more efficiently, targeted at subpopulations that are most likely to benefit from it.

An article was published as a part of a series in the Public Health Genomics Journal, outlining some of the market access barriers for companion diagnostics in the EU, including reimbursement challenges specific to some member states (Germany, the UK, and France). Furthermore, proposals addressing barriers and increasing timely patient access to companion diagnostics in the EU are presented.

organised by:
Market Access Group, EDMA
ALL DATES
SORT OPTIONS
SORT BY:
COUNTRY:
04 08 Jun
United Kingdom
Interviews with industry's thought leaders

United Kingdom

07:00 - 18:00